We are live on ! Find out more
DNTH icon

Dianthus Therapeutics
DNTH

45 hedge funds and large institutions have $22M invested in Dianthus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.07% less ownership

Funds ownership: 3.06% → 2.99% (-0.07%)

7% less capital invested

Capital invested by funds: $23.6M → $22M (-$1.56M)

12% less funds holding

Funds holding: 51 → 45 (-6)

17% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 12

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
45
Holders Change
-6
Holders Change %
-11.76%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
10
Reduced
12
Closed
9
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
+$8K

Top Buyers

1
NCM
Nantahala Capital Management
Connecticut
+$3.55M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.38M
3
OCA
Octagon Capital Advisors
New York
+$391K
4
Renaissance Technologies
Renaissance Technologies
New York
+$62.8K
5
CCM
Corsair Capital Management
New York
+$47.7K

Top Sellers

1
LPC
Lion Point Capital
New York
-$3.62M
2
Verition Fund Management
Verition Fund Management
Connecticut
-$1.29M
3
WSL
Western Standard LLC
California
-$1.14M
4
TG
TCW Group
California
-$596K
5
Morgan Stanley
Morgan Stanley
New York
-$356K
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
51
Virtu Financial
New York
– -$9K -670 Closed
BAM
52
Belpointe Asset Management
Nevada
– -$4.37K -344 Closed
Simplex Trading
53
Simplex Trading
Illinois
– -$2.3K -202 -100%
Fidelity Investments
54
Fidelity Investments
Massachusetts
– -$202 -16 Closed
1 2
3